Runtime 12:49 Craig Thompson welcomes high school students to the eighth annual Memorial Sloan Kettering Major Trends in Modern Cancer lecture. read more

Runtime 28:39 Leukemia expert Omar Abdel-Wahab says new therapies that reverse epigenetics — chemical changes within cells that drive gene expression — are being combined with conventional chemotherapy drugs to silence cancer-causing genes and treat some cancers.

Runtime 30:29 Scientist Emily Foley discusses the mechanics of cell division and its relevance to developing new cancer treatments. read more

Runtime 29:12 Oncologist and cancer biologist Richard White explains how his research with genetically modified zebrafish, which reproduce quickly and are optically transparent, has shed light on how melanoma and other cancers spread. read more

Memorial Sloan Kettering President and CEO Craig Thompson along with neuropathologist Jason Huse and immunologist Morgan Huse explain how recent developments contribute to better treatments for cancer patients. read more

Runtime 34:13 Immunologist Morgan Huse discusses how the orientation of T cells — a type of white blood cell — affects the way they mount an immune response. read more

Runtime 31:32 Neuropathologist Jason Huse discusses personalized medicine and how studying the molecular pathology of patients’ tumors can lead to new therapies. read more

Runtime 31:12 Memorial Sloan Kettering President and CEO Craig B. Thompson welcomes attendees to the seventh annual Major Trends in Modern Cancer Research lecture for high school students and introduces the speakers. read more

Runtime 110:45 Memorial Sloan Kettering President and CEO Craig Thompson along with cancer biologist Andrea Ventura, molecular biologist Iestyn Whitehouse, and developmental biologist Jennifer Zallen explain how recent developments contribute to better treatments for cancer patients. read more

Runtime 39:00 Physician-scientist Timothy A. Chan discusses cancer genomics at the forefront of cancer research and how developments have allowed researchers to discover what goes wrong in cancer faster than and more thoroughly. read more

Runtime 37:00 Developmental biologist Mary K. Baylies discusses the mechanisms that drive cells and how genetic approaches in flies have allowed us to find the fundamental genes and mechanisms driving muscle morphogenesis. read more

Runtime 32:00 Craig B. Thompson, President and CEO of Memorial Sloan Kettering Cancer Center, discusses new ways to think about cancer and how cancer arises in human beings. read more

Runtime 36:34 Director, Magnetic Resonance Imaging, Lawrence Schwartz, discusses the role of imaging in detection, characterization, staging, and in assessing the response to therapy in cancer treatment. read more

Runtime 40:38 Physician-scientist, Ross Levine, discusses how the study of genomic techniques can lead to the development of new treatments. read more

Runtime 04:19 Harold Varmus, co-recipient of the 1989 Nobel Prize for Physiology or Medicine, has served as the President of Memorial Sloan Kettering Cancer Center since January 2000. Watch Dr. Varmus introduce the seminar’s senior investigators. read more

Runtime 20:43 Students ask our scientists questions about research at Memorial Sloan Kettering and current cancer topics. read more

Runtime 23:52 Medical oncologist Kenneth Offit explains inherited mutations, hereditary disease, and its influences on cancer. read more

Runtime 33:55 Molecular biologist Prasad Jallepalli explains fundamental machinery and mechanisms of how cells divide. read more

Runtime 23:31 Developmental biologist Kathryn Anderson explains developmental biology and its relationship to cancer mutations occurring during life. read more

Runtime 02:57 Harold Varmus, co-recipient of the 1989 Nobel Prize for Physiology or Medicine, has served as the President of Memorial Sloan Kettering Cancer Center since January 2000. Watch Dr. Varmus introduce the seminar’s senior investigators. read more